Introduction
Thermotolerance is one of the major biological problems faced during the hyperthermic treatment of human cancer. 1 It is a phenomenon in which cells or tissues become resistant to elevated temperatures as a result of prior or continuous exposure to hyperthermia (HT). 2 Development of thermotolerance in tumor tissue during or after initial HT treatment reduces the tumoricidal effect of subsequent HT. Therefore, an agent or substance that can inhibit the development of thermotolerance in tumor tissue during repeated HT treatment would increase the tumor response and hence the therapeutic gain.
Withania somnifera Dunal, commonly known as ashwagandha in India, is an evergreen shrub of the Solanaceae family. The roots of the ashwagandha plant have been used as a valuable drug in the ayurvedic and Protein synthesis inhibitors can suppress the development of thermotolerance in tumor tissues during repeated heating. Withaferin a (Wa), isolated from Withania somnifera has cytotoxic and inhibitory action on protein synthesis. In the present investigation, effect of Wa on development and decay of thermotolerance in B16F1 melanoma was studied in C57BL mice. Tumors of 100 ± 10 mm 3 size were subjected to repeated hyperthermia (HT) at 43°C for 30 minutes. Wa was injected after first hyperthermia treatment. The tumor response was assessed by calculating the tumor growth delay (GD). The GD increased with increase in time gap between two hyperthermia treatments and was significantly higher (p < 0.05 to p < 0.001) in Wa treated groups at all the respective time gaps (except at 0h and 120h) compared to hyperthermia alone group. Wa increases the tumor response during repeated hyperthermia by reducing the magnitude of thermotolerance developed and by decreasing the recovery time from thermotolerance. Keywords: Hyperthermia; Thermotolerance; Withaferin a; B16F1 melanoma; Growth delay. containing sterile paddy husk as bedding and maintained under controlled conditions of temperature (23 ± 2°C), humidity (50 ± 5%), and light (10:14 light and dark, respectively). The animals were fed with standard mouse feed and filtered acidified water ad libitum.
Tumor Model
The transplantable mouse tumor, B16F1 melanoma, was obtained from the Cancer Research Institute, Mumbai, India, and propagated in adult C57BL mice. For experiments, 5 × 10 5 viable melanoma cells were injected intradermally on the dorsal skin of the mice. Tumors measuring 100 ± 10 mm 3 in size were used for all the experiments.
Hyperthermia
The animals were anesthetized by intraperitoneal (i.p.) injection of 50 mg/kg ketamine and 0.25 mg/mouse of diazepam and restrained in a perspex sheet. The tumors were immersed in a thermostat-controlled circulating water bath (Julabo, Germany) maintained at 43°C. 15 Tumor temperatures were measured using microprobes (0.33 mm in diameter, 10 mm long, Sensortek, USa) attached to a digital thermometer, which is explained elsewhere. 16
Drug Isolation and Characterization
W somnifera root powder was a kind gift from Vaipa Pharmaceuticals Ltd, Gujarat, India. Wa was isolated from the alcoholic extract of W somnifera root powder using the method of Subramanian and Sethi 17 as standardized in our laboratory with minor modifications. 18 Briefly, the dried root powder was extracted with 95% ethanol at 60°C to 80°C in a Soxhalet apparatus using the method of Suffness and Douros. 19 The excess solvent was distilled off and dried in a Speedvac vacuum drier (Savant, SC110a, USa). The ethanolic extract (100 g) was mixed thoroughly with 100 mL double distilled water, which was later fractionated with petroleum ether, ether, and chloroform in succession. The ether and chloroform fractions were chromatographed on neutral alumina by washing the column with petroleum ether, petroleum ether-benzene, benzene, benzene-chloroform, and finally chloroform.
Wa was separated from these fractions by subjecting them to thin-layer chromatography using silica gel as the stationary phase and ethyl acetate-benzene as the mobile phase. Wa has an R f value of 0.39 with a molecular weight of 470. approximate yield was 0.05%. The purity of the sample was confirmed by color reactions, cochromatography, and UV spectra. In addition, the authenticity of the sample was confirmed by comparing the HPLC spectra with pure Wa sample obtained from Sigma Inc, Minnesota.
Because Wa is insoluble in water, it was dissolved in a few drops of absolute ethanol, and a suspension was made in 0.5% carboxymethylcellulose in phosphatebuffered saline (pH 7.4). Freshly prepared drug was used for each experiment.
Experimental Design

Effect of WA Treatment on Growth Kinetics During Repeated HT
The animals bearing 100 ± 10 mm 3 tumors were divided into 2 groups and treated as follows. For each time point, 8 to 10 animals were taken.
Controls. Tumors were subjected to HT treatment (43°C for 30 minutes, locally) followed immediately by injection of 0.5% carboxymethylcellulose (i.p.) in phosphatebuffered saline. a second HT treatment was given at 0, 24, 48, 72, 96, 120, 144, and 168 hours after the first HT treatment.
WA + HT. Tumors were subjected to the first HT treatment (43°C, 30 minutes, locally) followed immediately by Wa injection (40 mg/kg, i.p.). Tumors were subjected to the second HT treatment at 0, 24, 48, 72, 96, 120, 144, and 168 hours after the first HT treatment.
Parameters
The day on which the first HT treatment was given was considered as day 0. The tumors were measured on alternate days after the treatment using a Vernier caliper in 3 perpendicular diameters (D 1 , D 2 , and D 3 ), and the tumor volume was calculated using the formula V= (π/6) (D 1 × D 2 × D 3 ). 15 Tumor response was studied by calculating growth delay (GD), which is defined as the difference in time (in days) between the control and treated tumors to reach 5 times the treatment volume.
The experiments were performed according to the norms of the Institutional animal ethical Committee.
Statistical Analysis
all the data were analyzed using Student's t test (Graph Pad Instat Software, v. 1.13).
Results
Heating the tumors at 43°C for 1 hour (0 hour time gap between 2 HT treatments) produced a remarkable increase in GD (9.35 ± 0.728 days) compared with single HT treatment (GD= 4.79 ± 0.38 days). Wa treatment immediately after the first HT treatment during continuous HT treatment for 1 hour did not produce any significant effect compared with HT alone (Figure 2 ). However, when the time gap between 2 HT treatments was increased to 24 hours, a sudden decrease in GD (1.8 ± 0.23 days) was observed in control tumors, which increased significantly to 3.14 ± 0.51 days (P < .05) by Wa treatment. above a time gap of 24 hours, a gradual increase in GD with increase in time gap between 2 HT treatments was observed in control tumors. In the Wa + HT group, GD was significantly higher (P < .01 to P < .001) than in controls at all the respective time gaps (except for the 0 hour interval). In the Wa-treated group, GD reached the 0 hour interval value (13.51 ± 0.83 days) at the 144 hour interval. at a gap of 168 hours, GD in the Wa-treated group was almost 2 times higher (20.22 ± 2.35 days) than in the HT alone group.
Discussion
Growth delay has been used as a standard end point to study the kinetics of thermotolerance in tumor tissue. 20 In the present study, the higher GD observed after continuous HT for 60 minutes than after HT for 30 minutes suggests that in B16F1 melanoma, thermotolerance develops after the completion of HT and not during the treatment. However, higher tumor GD caused by increased thermal damage and decreased cell survival after prolonged heating 15,21 cannot be neglected.
During the fractionated HT treatment, the first heat dose may kill the thermally vulnerable hypoxic cells and cells that are in the S-phase of the cell cycle. 22 The remaining cells may become refractory to the second HT treatment. However, thermotolerance may not develop in the cells when the interval between 2 HT treatments is too short, leading to high thermal damage. Henle and Leeper 23 have demonstrated that an interlude at 37°C is required to allow the cells to recover from the hyperthermic stress at or above 43°C. In vivo studies have shown that the development of thermotolerance takes 12 to 24 hours after the initial heat treatment 20 based on the extent of initial heat treatment, gap between the 2 HT treatments, and the tumor type. 21 In the present investigation, the drastic decrease in GD observed when 2 HT treatments were given after a gap of 24 hours suggests the development of thermotolerance in the tumor tissue. However, thermotolerance might have already developed much before 24 hours, the earliest interval studied in the present investigation and might have started decaying by this time. This is evident from the results of the apoptosis assay.
Thermotolerance is known to decay exponentially after reaching its maximum with increase in the fractionation interval. 24 The result of the present investigation shows that above an interval of 24 hours, thermotolerance started decaying and the decay was complete by 168 hours. These findings are comparable with those of an earlier study by Kaneko et al, 25 which showed that heating SCCVII tumors at 44°C for 30 minutes followed by a challenge dose of 44°C for 90 minutes resulted in a maximum thermotolerance at 12 hours and complete decay at 120 hours. The increase in time required for the complete decay of thermotolerance observed in the present investigation may be a result of the difference in the heat sensitivities of the tumor models, difference in the treatment temperature, and duration of HT treatment. B16F1 melanoma is a hypoxic tumor 26 in which the extent of damage by first heat treatment is expected to be higher. In an earlier study, we observed that heating the tumor at 43°C for 30 minutes resulted in decrease in microvessel density and increase in apoptotic cells. 16 Urano 1 has shown that decay of thermotolerance depends on the extent of thermal damage in the tissue after initial heating. This may explain the slow decay of thermotolerance observed in this tumor model. a close correlation between thermotolerance and the presence of heat shock proteins (Hsps) was demonstrated in earlier studies. 25, 27 Inhibition of synthesis of Hsps, which were assumed to be necessary for the protection and recovery of cells from stress, was found to suppress the development of thermotolerance. 28, 29 The protective role of Hsp on apoptosis during repeated HT treatment has been demonstrated by Shibuya et al. 30 Synthesis and degradation of Hsp is a time-dependent process. at 24 hours after initial heat treatment, the level of Hsps may be at a maximum, which may explain the maximum thermotolerance observed at the 24 hour interval, and their subsequent degradation with increase in time may reduce the protective effect on apoptosis leading to a higher cell kill by HT.
In the present investigation, although Wa was not able to completely inhibit the development of thermotolerance, it was able to reduce the magnitude of thermotolerance developed and induce a faster recovery of tumor tissue from thermotolerance compared with HT alone. The Wa dose used in the present investigation (40 mg/kg) was reported to have a weak antitumor activity, 8 without any significant hyperthermic sensitizing effect on the tumor. This may explain the nonsignificant effect of Wa on HT-induced GD compared with HT alone for 1 hour in the present investigation. The significant increase in GD observed in Wa-treated groups compared with HT-alone groups with increase in time gap between 2 HT treatments and a significant decrease in time required for complete recovery of the tumor cells from thermotolerance suggests that Wa may have an effect on the synthesis and degradation of Hsps. earlier studies have demonstrated that Wa has a significant inhibitory effect on DNa, RNa, and protein synthesis in P388 leukemia cells. 11, 12 after a heat stress, synthesis of the Hsps is a predominant process in the tissue. Inhibition of incorporation amino acids like valine and cysteine into the growing polypeptide by Wa 12 may lead to decrease in Hsp synthesis in the tumor tissue. It has been shown that protein synthesis inhibitors like cyclohexamide, 13 amino acid analogues, 14 and a synthetic compound KNK437 28, 29 inhibit the development of thermotolerance in tumors by inhibiting Hsp synthesis. It was demonstrated that quercetin, a bioflavonoid, inhibited thermotolerance in the tumor tissue 31 by increasing the cell death by apoptosis by inhibiting Hsp synthesis. 32 In conclusion, these results suggest that Wa increases the tumor response during repeated HT treatment by decreasing the magnitude of thermotolerance developed and by reducing the recovery time from thermotolerance. However, further studies are required to investigate the effect of Wa on Hsp synthesis and its role in the kinetics of thermotolerance.
